UnitedHealth's Downtrend Continues as Stock Tests Support Level

UnitedHealth Group's shares have slipped to $376.90 on the NYSE, leaving them just above their recent floor and still trading below both short- and medium-term trend lines. This is notable because it shows that a large, defensive health-care name is not being treated as a safe haven by the market right now.

The stock remains in a downtrend, with its SMA20 at $390.30 and SMA50 at $404.33 both sitting above the current price. When price stays below both moving averages, rallies tend to be treated as recovery attempts rather than confirmed trend reversals.

There is no fresh moving-average crossover to suggest a new trend regime, which means the chart has not yet produced the kind of technical reset that usually accompanies a durable rebound. The stock is not collapsing in a straight line, but it is still drifting under overhead resistance from its own trend markers.